MEDIA
Purdue Pharma Judge Throttles ‘Misinformed,’ ‘Numbskull’ New York Times Opinion Writers
MEDIA

Purdue Pharma Judge Throttles ‘Misinformed,’ ‘Numbskull’ New York Times Opinion Writers

Published: July 29, 2020  |  8 min read, 1643 words
WRITTEN BY
Your review will affect the following:
The prescription medicine OxyContin is part of the Purdue Pharma litigation. (Photo by Darren McCollester/Getty Images)A federal judge overseeing Purdue Pharma’s multi-billion-dollar bankruptcy proceeding has lashed out the press — and, by logical conclusion, the New York Times in particular — largely because of an opinion piece concerning the family which controls the pharmaceutical giant, the massive company itself, and several of the company’s products, which include the drug OxyContin.  Judge Robert D. Drain, of the , went so far as to call a “misinformed reporter” both an “idiot” and a... READ MORE
CRITIC
N/A
N/Ano rating
Critic Reviews: N/A
We calculate ratings after a minimum of three reviews.
USER
N/A
N/Ano rating
User Reviews: N/A
We calculate ratings after a minimum of three reviews.
TOP REVIEWS
There are no reviews yet.

CRITIC REVIEWS

There don't seem to be any reviews yet.

PUBLIC REVIEWS

There don't seem to be any reviews yet.